サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1400997

ヒト絨毛性ゴナドトロピン（hCG）市場：技術別、治療領域別、エンドユーザー別、国別、地域別 - 2023年～2030年、産業分析、市場規模、市場シェア、予測

Human Chorionic Gonadotropin (hCG) Market with COVID-19 Impact Analysis by Technology, Therapeutic Area, End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 288 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
ヒト絨毛性ゴナドトロピン（hCG）市場：技術別、治療領域別、エンドユーザー別、国別、地域別 - 2023年～2030年、産業分析、市場規模、市場シェア、予測
出版日: 2023年12月17日
発行: AnalystView Market Insights
ページ情報: 英文 288 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

ヒト絨毛性ゴナドトロピン（hCG）市場規模は2022年に7億1,087万米ドルとなり、2023年から2030年にかけてCAGR 6.48％で拡大

ヒト絨毛性ゴナドトロピン（hCG）市場 -市場力学

不妊症と性腺機能低下症の有病率の増加、ライフスタイルの変化、不妊治療に関する意識の高まりが市場需要を促進する

不妊症や性腺機能低下症の有病率の上昇、ライフスタイルの変化、不妊治療に関する知識の向上などが、ヒト絨毛性ゴナドトロピン（HCG）産業の拡大に寄与しています。例えば、性腺機能低下症は、血清中のホルモンであるテストステロン濃度が低いことで定義され、朝勃ちが悪い、ED、記憶力低下、性欲減退、健康状態や体力の低下、集中力の低下、うつ状態など、さまざまな臨床的特徴が見られます。2021年7月にBMC Endocrine Disordersによって発表された調査によると、勃起不全は2021年には世界の成人の72.2％に影響を及ぼします。

ヒト絨毛性ゴナドトロピン（hCG）市場 - 主要洞察

当社のリサーチアナリストが共有した分析によると、世界のヒト絨毛性ゴナドトロピン（hCG）市場は、予測期間（2023年～2030年）に約6.48％のCAGRで毎年成長すると予測されています。

ヒト絨毛性ゴナドトロピン（hCG）産業は、不妊症や性腺機能低下症の有病率の増加、ライフスタイルの変化、不妊治療に関する意識の高まりにより、著しい速度で成長すると予測される

技術セグメンテーションに基づくと、天然源抽出が2022年に最大の市場シェアを示すと予測されます。

治療分野別では、女性不妊治療が2022年の主要技術でした。

エンドユーザー別では、不妊治療クリニックが2022年の主要技術でした。

地域別では、北米が2022年の主要収益源でした。

ヒト絨毛性ゴナドトロピン（hCG）市場 - セグメンテーション分析：

ヒト絨毛性ゴナドトロピン（hCG）の世界市場は、技術、治療領域、エンドユーザー、地域に基づいてセグメント化されます。

市場は、製品技術に基づいてカテゴリに分かれています：組換え技術と天然源抽出。天然源抽出セグメントは世界市場を独占しており、予測期間中もそうである可能性が高いです。hCG分野の大手競合企業は、天然源由来のゴナドトロピンに対する高い需要を有しており、これは過去数年間における市場の重要な開拓であり、この分野が得る収入に大きく貢献しています。

市場は治療領域に基づいてカテゴリー分けされている：男性性腺機能低下症、女性不妊治療、乏精子症治療、その他です。不妊症とは、夫婦が妊娠できないこと、あるいは女性が妊娠を継続できないことを指します。ヒト絨毛性ゴナドトロピン（HCG）ホルモンは、妊娠中の胚の発育に続いて重要であるため、不妊治療におけるHCGの使用は、男女を問わず人気があります。女性の不妊の原因はさまざまです。世界保健機関（WHO）によると、子宮の病気、卵管の詰まり、卵胞の問題、多嚢胞性卵巣症候群（PCOS）、様々な内分泌系疾患などの卵管異常が主な原因として挙げられています。

ヒト絨毛性ゴナドトロピン（hCG）市場 - 地理的洞察

地理的に、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東アフリカの地域に広がっています。これらの地域は、ビジネスをもたらす国ごとにさらに分割されます。予測期間中、北米はかなりの市場成長が見込まれます。この増加は、この地域の確立されたヘルスケア・インフラ、有利な償還規制、不妊症の負担増に関連しています。

ヒト絨毛性ゴナドトロピン（hCG）市場 - 競合情勢：

企業は、企業ウェブサイト、eコマースウェブサイト、小売業者、流通業者、最終消費者など、さまざまなチャネルを通じて製品を販売しています。リーチを強化し市場シェアを拡大するために企業が用いる主な手法には、新製品の発売、流通網開拓、研究開発費、M&Aなどがあります。例えば、2022年6月、イントロダクション・ファーティリティは、不妊治療の専門家と患者に唯一無二の体験を提供する長期生体組織・凍結保存ソリューションであるHavenCryoを発表し、エコシステムを拡大しました。

目次

第1章 ヒト絨毛性ゴナドトロピン（hCG）市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 ヒト絨毛性ゴナドトロピン（hCG）の主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 ヒト絨毛性ゴナドトロピン（hCG）産業調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 ヒト絨毛性ゴナドトロピン（hCG）市場：COVID-19感染症の影響分析

  • 新型コロナウイルス感染症以前の影響分析
  • 新型コロナウイルス感染症後の影響分析

第6章 ヒト絨毛性ゴナドトロピン（hCG）市場情勢

  • ヒト絨毛性ゴナドトロピン（hCG）市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 ヒト絨毛性ゴナドトロピン（hCG）市場 - 技術別

  • 概要
    • セグメントシェア分析（技術別）
    • リコンビナント
    • 天然抽出物

第8章 ヒト絨毛性ゴナドトロピン（hCG）市場 - 治療領域別

  • 概要
    • 疾患領域別のセグメントシェア分析
    • 男性の性腺機能低下症
    • 女性の不妊治療
    • 乏精子症の治療
    • その他

第9章 ヒト絨毛性ゴナドトロピン（hCG）市場 - エンドユーザー別

  • 概要
    • エンドユーザー別のセグメントシェア分析
    • 研究機関
    • 不妊クリニック
    • その他

第10章 ヒト絨毛性ゴナドトロピン（hCG）市場 - 地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析 - ヒト絨毛性ゴナドトロピン（hCG）産業

  • 競合ダッシュボード
  • 企業プロファイル
    • Zydus Cadila
    • Torrent Pharmaceuticals
    • Sun Pharmaceutical Industries Ltd.
    • Sigma-Aldrich（now part of MilliporeSigma）
    • Organon
    • Novartis
    • Merck
    • Mankind Pharma
    • Lupin Pharmaceuticals
    • Liqvor Pharmaceuticals
    • IBSA Pharma
    • Glenmark Pharmaceuticals
    • Ferring Pharmaceuticals
    • Bharat Serums and Vaccines Ltd.
    • Anhui Anke Biotechnology（Anhui Anke Biotechnology Co., Ltd.）

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Human Chorionic Gonadotropin (hCG) Market: Technology Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Technology
  • TABLE Global Human Chorionic Gonadotropin (hCG) Market, by Technology 2018-2030 (USD Million)
  • TABLE Human Chorionic Gonadotropin (hCG) Market: Therapeutic Area Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Therapeutic Area
  • TABLE Global Human Chorionic Gonadotropin (hCG) Market, by Therapeutic Area 2018-2030 (USD Million)
  • TABLE Human Chorionic Gonadotropin (hCG) Market: End User Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Human Chorionic Gonadotropin (hCG) Market, by End User 2018-2030 (USD Million)
  • TABLE Human Chorionic Gonadotropin (hCG) Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Human Chorionic Gonadotropin (hCG) Market, by Region 2018-2030 (USD Million)
  • TABLE North America Human Chorionic Gonadotropin (hCG) Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Human Chorionic Gonadotropin (hCG) Market, by Technology, 2018-2030 (USD Million)
  • TABLE North America Human Chorionic Gonadotropin (hCG) Market, by Therapeutic Area, 2018-2030 (USD Million)
  • TABLE North America Human Chorionic Gonadotropin (hCG) Market, by End User, 2018-2030 (USD Million)
  • TABLE Europe Human Chorionic Gonadotropin (hCG) Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Human Chorionic Gonadotropin (hCG) Market, by Technology, 2018-2030 (USD Million)
  • TABLE Europe Human Chorionic Gonadotropin (hCG) Market, by Therapeutic Area, 2018-2030 (USD Million)
  • TABLE Europe Human Chorionic Gonadotropin (hCG) Market, by End User, 2018-2030 (USD Million)
  • TABLE Asia Pacific Human Chorionic Gonadotropin (hCG) Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Human Chorionic Gonadotropin (hCG) Market, by Technology, 2018-2030 (USD Million)
  • TABLE Asia Pacific Human Chorionic Gonadotropin (hCG) Market, by Therapeutic Area, 2018-2030 (USD Million)
  • TABLE Asia Pacific Human Chorionic Gonadotropin (hCG) Market, by End User, 2018-2030 (USD Million)
  • TABLE Latin America Human Chorionic Gonadotropin (hCG) Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Human Chorionic Gonadotropin (hCG) Market, by Technology, 2018-2030 (USD Million)
  • TABLE Latin America Human Chorionic Gonadotropin (hCG) Market, by Therapeutic Area, 2018-2030 (USD Million)
  • TABLE Latin America Human Chorionic Gonadotropin (hCG) Market, by End User, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Human Chorionic Gonadotropin (hCG) Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Human Chorionic Gonadotropin (hCG) Market, by Technology, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Human Chorionic Gonadotropin (hCG) Market, by Therapeutic Area, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Human Chorionic Gonadotropin (hCG) Market, by End User, 2018-2030 (USD Million)

List of Figures

  • FIGURE Human Chorionic Gonadotropin (hCG) Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Technology segment market share analysis, 2022 & 2030
  • FIGURE Technology segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Therapeutic Area segment market share analysis, 2022 & 2030
  • FIGURE Therapeutic Area segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE End User segment market share analysis, 2022 & 2030
  • FIGURE End User segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Human Chorionic Gonadotropin (hCG) Market share and leading players, 2022
  • FIGURE Europe Human Chorionic Gonadotropin (hCG) Market share and leading players, 2022
  • FIGURE Asia Pacific Human Chorionic Gonadotropin (hCG) Market share and leading players, 2022
  • FIGURE Latin America Human Chorionic Gonadotropin (hCG) Market share and leading players, 2022
  • FIGURE Middle East and Africa Human Chorionic Gonadotropin (hCG) Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Human Chorionic Gonadotropin (hCG) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Human Chorionic Gonadotropin (hCG) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Human Chorionic Gonadotropin (hCG) Market share analysis by country, 2022
  • FIGURE Germany Human Chorionic Gonadotropin (hCG) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Human Chorionic Gonadotropin (hCG) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Human Chorionic Gonadotropin (hCG) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Human Chorionic Gonadotropin (hCG) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Human Chorionic Gonadotropin (hCG) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Human Chorionic Gonadotropin (hCG) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Human Chorionic Gonadotropin (hCG) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Human Chorionic Gonadotropin (hCG) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Human Chorionic Gonadotropin (hCG) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Human Chorionic Gonadotropin (hCG) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Human Chorionic Gonadotropin (hCG) Market share analysis by country, 2022
  • FIGURE India Human Chorionic Gonadotropin (hCG) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Human Chorionic Gonadotropin (hCG) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Human Chorionic Gonadotropin (hCG) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Human Chorionic Gonadotropin (hCG) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Human Chorionic Gonadotropin (hCG) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Human Chorionic Gonadotropin (hCG) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Human Chorionic Gonadotropin (hCG) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Human Chorionic Gonadotropin (hCG) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Human Chorionic Gonadotropin (hCG) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Human Chorionic Gonadotropin (hCG) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Human Chorionic Gonadotropin (hCG) Market share analysis by country, 2022
  • FIGURE Brazil Human Chorionic Gonadotropin (hCG) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Human Chorionic Gonadotropin (hCG) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Human Chorionic Gonadotropin (hCG) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Human Chorionic Gonadotropin (hCG) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Human Chorionic Gonadotropin (hCG) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Human Chorionic Gonadotropin (hCG) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Human Chorionic Gonadotropin (hCG) Market share analysis by country, 2022
  • FIGURE Saudi Arabia Human Chorionic Gonadotropin (hCG) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Human Chorionic Gonadotropin (hCG) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Human Chorionic Gonadotropin (hCG) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Human Chorionic Gonadotropin (hCG) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Human Chorionic Gonadotropin (hCG) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Human Chorionic Gonadotropin (hCG) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Human Chorionic Gonadotropin (hCG) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV1961

REPORT HIGHLIGHT

Human Chorionic Gonadotropin (hCG) Market size was valued at USD 710.87 Million in 2022, expanding at a CAGR of 6.48% from 2023 to 2030.

Human Chorionic Gonadotropin (hCG) is a hormone generated by the placenta during pregnancy. It aids pregnancy by activating the corpus luteum in the ovaries to generate progesterone, which maintains the uterine lining and helps the growing fetus. hCG is also the hormone discovered in pregnancy tests since its levels grow considerably early in pregnancy. In addition to its role in reproduction, hCG has therapeutic applications, including as in fertility therapies and as a marker for various medical disorders, including several cancer technologies.

Human Chorionic Gonadotropin (hCG) Market- Market Dynamics

Increasing prevalence of infertility and hypogonadism, changing lifestyles, and increased awareness regarding infertility treatment to propel market demand

The rising prevalence of infertility and hypogonadism, changing lifestyles, and improved knowledge about infertility therapy are all contributing to the expansion of the human chorionic gonadotropin (HCG) industry. Hypogonadism, for example, is defined by low serum the hormone testosterone concentration, which is followed by an array of clinical features such as poor morning erections, ED, memory loss, low libido, physical decline in health and power, difficulty concentrating, and depression. According to research published in July 2021 by BMC Endocrine Disorders, erectile dysfunction would affect 72.2% of adults worldwide in 2021.

Human Chorionic Gonadotropin (hCG) Market- Key Insights

As per the analysis shared by our research analyst, the global Human Chorionic Gonadotropin (hCG) market is estimated to grow annually at a CAGR of around 6.48% over the forecast period (2023-2030)

The Human Chorionic Gonadotropin (hCG) industry is projected to grow at a significant rate due to the increasing prevalence of infertility and hypogonadism, changing lifestyles, and increased awareness regarding infertility treatment

Based on Technology segmentation, natural source extraction was predicted to show maximum market share in the year 2022

Based on Therapeutic Area segmentation, Female Infertility Treatment was the leading Technology in 2022

Based on end user segmentation, Fertility Clinics was the leading Technology in 2022

On the basis of region, North America was the leading revenue generator in 2022

Human Chorionic Gonadotropin (hCG) Market- Segmentation Analysis:

The Global Human Chorionic Gonadotropin (hCG) Market is segmented on the basis of Technology, Therapeutic Area, End User, and Region.

The market is divided into categories based on product Technology: Recombinant Technology and Natural Source Extraction. The natural source extraction segment dominated the worldwide market and is likely to continue to do so during the forecast period. The leading competitors in the hCG sector have a high demand for gonadotropins derived from natural sources, which has been an important development in the market over the past few years and has contributed significantly to the income earned by this segment.

The market is divided into categories based on Therapeutic Area: Male Hypogonadism, Female Infertility Treatment, Oligospermia Treatment, and Others. Infertility is described as the couple's inability to become pregnant or the woman's inability to sustain a pregnancy to term. Because the human chorionic gonadotropin (HCG) hormone is important following embryo development during pregnancy, its usage in infertility therapy has gained popularity in both men and women. Female infertility can be caused by a variety of factors. Tubal abnormalities such as a uterine illness, blocked fallopian tube, follicular problems, polycystic ovarian syndrome (PCOS), various and endocrine system disorders are among the leading causes, according to the World Health Organization.

Human Chorionic Gonadotropin (hCG) Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. Over the projection period, North America is expected to experience considerable market growth. The rise can be linked to the region's well-established healthcare infrastructure, advantageous reimbursement regulations, and the rising burden of infertility.

Human Chorionic Gonadotropin (hCG) Market- Competitive Landscape:

Companies sell their products through a variety of channels, including corporate websites, e-commerce websites, retailers, distributors, and end consumers. Some of the primary techniques used by corporations to strengthen their reach and expand their market share include new product launches, distribution network development, R&D spending, and mergers and acquisitions. For instance, in June 2022, Inception Fertility extended its ecosystem with the introduction of HavenCryo, a long-term biological tissue and cryopreservation preservation solution that provides fertility professionals and patients with a one-of-a-kind experience.

Recent Developments:

In June 2022, with the introduction of HavenCryo, a long-term reproductive tissue and cryopreservation storage solution that provides a distinctive experience for fertility practitioners and patients, Inception Fertility extended its ecosystem.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HUMAN CHORIONIC GONADOTROPIN (HCG) MARKET KEY PLAYERS

  • Zydus Cadila
  • Torrent Pharmaceuticals
  • Sun Pharmaceutical Industries Ltd.
  • Sigma-Aldrich (now part of MilliporeSigma)
  • Organon
  • Novartis
  • Merck
  • Mankind Pharma
  • Lupin Pharmaceuticals
  • Liqvor Pharmaceuticals
  • IBSA Pharma
  • Glenmark Pharmaceuticals
  • Ferring Pharmaceuticals
  • Bharat Serums and Vaccines Ltd.
  • Anhui Anke Biotechnology (Anhui Anke Biotechnology Co., Ltd.)

GLOBAL HUMAN CHORIONIC GONADOTROPIN (HCG) MARKET, BY TECHNOLOGY

  • Recombinant Technology
  • Natural Source Extraction

GLOBAL HUMAN CHORIONIC GONADOTROPIN (HCG) MARKET, BY THERAPEUTIC AREA

  • Male Hypogonadism
  • Female Infertility Treatment
  • Oligospermia Treatment
  • Others

GLOBAL HUMAN CHORIONIC GONADOTROPIN (HCG) MARKET, BY END USER

  • Research Institutes
  • Fertility Clinics
  • Others

GLOBAL HUMAN CHORIONIC GONADOTROPIN (HCG) MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Human Chorionic Gonadotropin (hCG) Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Human Chorionic Gonadotropin (hCG) Market Snippet by Technology
    • 2.1.2. Human Chorionic Gonadotropin (hCG) Market Snippet by Therapeutic Area
    • 2.1.3. Human Chorionic Gonadotropin (hCG) Market Snippet by End User
    • 2.1.4. Human Chorionic Gonadotropin (hCG) Market Snippet by Country
    • 2.1.5. Human Chorionic Gonadotropin (hCG) Market Snippet by Region
  • 2.2. Competitive Insights

3. Human Chorionic Gonadotropin (hCG) Key Market Trends

  • 3.1. Human Chorionic Gonadotropin (hCG) Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Human Chorionic Gonadotropin (hCG) Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Human Chorionic Gonadotropin (hCG) Market Opportunities
  • 3.4. Human Chorionic Gonadotropin (hCG) Market Future Trends

4. Human Chorionic Gonadotropin (hCG) Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Human Chorionic Gonadotropin (hCG) Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Human Chorionic Gonadotropin (hCG) Market Landscape

  • 6.1. Human Chorionic Gonadotropin (hCG) Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Human Chorionic Gonadotropin (hCG) Market - By Technology

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Technology, 2022 & 2030 (%)
    • 7.1.2. Recombinant Technology
    • 7.1.3. Natural Source Extraction

8. Human Chorionic Gonadotropin (hCG) Market - By Therapeutic Area

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Therapeutic Area, 2022 & 2030 (%)
    • 8.1.2. Male Hypogonadism
    • 8.1.3. Female Infertility Treatment
    • 8.1.4. Oligospermia Treatment
    • 8.1.5. Others

9. Human Chorionic Gonadotropin (hCG) Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2022 & 2030 (%)
    • 9.1.2. Research Institutes
    • 9.1.3. Fertility Clinics
    • 9.1.4. Others

10. Human Chorionic Gonadotropin (hCG) Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Human Chorionic Gonadotropin (hCG) Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Human Chorionic Gonadotropin (hCG) Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Human Chorionic Gonadotropin (hCG) Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Human Chorionic Gonadotropin (hCG) Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Human Chorionic Gonadotropin (hCG) Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Human Chorionic Gonadotropin (hCG) Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Zydus Cadila
    • 11.2.2. Torrent Pharmaceuticals
    • 11.2.3. Sun Pharmaceutical Industries Ltd.
    • 11.2.4. Sigma-Aldrich (now part of MilliporeSigma)
    • 11.2.5. Organon
    • 11.2.6. Novartis
    • 11.2.7. Merck
    • 11.2.8. Mankind Pharma
    • 11.2.9. Lupin Pharmaceuticals
    • 11.2.10. Liqvor Pharmaceuticals
    • 11.2.11. IBSA Pharma
    • 11.2.12. Glenmark Pharmaceuticals
    • 11.2.13. Ferring Pharmaceuticals
    • 11.2.14. Bharat Serums and Vaccines Ltd.
    • 11.2.15. Anhui Anke Biotechnology (Anhui Anke Biotechnology Co., Ltd.)

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us